A High-Throughput Assay for Connexin 43 (Cx43, GJA1) Gap Junctions Using Codon-Optimized Aequorin

Diversity and properties of connexin gap junction channels

(2018) Mindaugas Račkauskas et al.   Medicina-Lithuania

Modafinil Increases Arousal Determined by P13 Potential Amplitude: An Effect Blocked by Gap Junction Antagonists

(2017) Paige Beck et al.   SLEEP

Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure

(2012) Suraj J Patel et al.   NATURE BIOTECHNOLOGY

Pharmacological modulation of connexin-formed channels in cardiac pathophysiology

(2011) Elke De Vuyst et al.   BRITISH JOURNAL OF PHARMACOLOGY

Assay for molecular transport across gap junction channels in one-dimensional cell arrays

(2011) Nannan Ye et al.   LAB ON A CHIP

A novel mutation in the connexin 26 gene (GJB2) in a child with clinical and histological features of keratitis-ichthyosis-deafness (KID) syndrome

(2010) U. Koppelhus et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Connexin Modulators and Their Potential Targets under the Magnifying Glass

(2010) S. B. Bodendiek et al.   CURRENT MEDICINAL CHEMISTRY

Non-invasive microfluidic gap junction assay

(2010) Sisi Chen et al.   Integrative Biology

Connexin 43 mimetic peptide Gap26 confers protection to intact heart against myocardial ischemia injury

(2010) Ghayda Hawat et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

A description of the structural determination procedures of a gap junction channel at 3.5 Å resolution

(2009) Michihiro Suga et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Tonabersat, a Gap-Junction Modulator: Efficacy and Safety in Two Randomized, Placebo-Controlled, Dose-Ranging Studies of Acute Migraineceph

(2009) SD Silberstein et al.   CEPHALALGIA

Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)13, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation

(2009) John A. Butera et al.   JOURNAL OF MEDICINAL CHEMISTRY

The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model

(2009) E. I. Rossman et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides

(2009) Stefan Dhein et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY